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Abstract. Cobalt is the essential trace microelement which is an indispensable part of several enzymes
and co-enzymes. Cobalt ions may enter the environment from both natural sources and human activities.
This metal is very widespread in the natural environment and can be formed as an effect of anthropogenic
activity. Toxic activities of cobalt and its compounds depend on the physical and chemical properties of
these complexes, including their electronic structure, ion parameters (charge-size relations) and kinetics.
Cobalt has both beneficial and harmful effects on human health. Cobalt is beneficial for humans because
it is part of vitamin B12, which is essential to maintain human health. Exposure of humans and animals to
levels of cobalt normally found in the environment is not harmful. When excessive cobalt amount enter
into human body multiple and chronic harmful health effects can occur and the longer the cobalt ions are
stored in the body, the more changes they cause in cells.  Cobalt gets into the body in several ways:
mainly by food, by the respiratory system, by the skin or as a component of various biomaterials.  Despite
this metal abundancy much of our knowledge of cobalt toxicity is based mainly on the animal studies.
Undoubtedly, inorganic forms of cobalt are toxic, accumulate in various tissues and can evoke a chain of
pathological cascade changes in the cells. Though some cobalt effects might be beneficial for medicine.
Therefore,  the  purpose  of  our  review  is  to  provide  the  current  analysis  about  the  most  significant
regulatory, pathophysiological and the epigenetic effects of Co2+ in the human body.
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epigenetics.
1. Introduction
The environmental pollution by xenobiotics is one of global unresolved problems, the relevance of which
increased even more in the 21st century. Among  modern xenobiotics the leading position is occupied by
salts of heavy non-ferrous metals, which are extracted in large quantities into the human habitat. These
include toxic trace elements such as: lead, cadmium, cobalt, chromium, mercury, aluminum, etc. Heavy
nonferrous metals enter the body not only through the gastrointestinal tract, which is most vulnerable to
the action of man-made exotoxicants, but also through the respiratory organs, integuments and mucous
membranes, especially with a decreased barrier functions.
 According to the modern data rather high bioavailability of cobalt salts and the presence of metal mineral
compounds in human trophic chains can be caused by both endemic geochemical factors and the human
activity itself associated with the operation of coal-fired power plants, the production of certain foods, the
mining and processing of metals, medical alloys, ceramics, household waste disposal, etc.  (Hokin B. et
al., 2004; Gál J. et al., 2008; EFSA Panel on Additives, 2009; Tvermoes B.E. et al., 2015).   There is
numerous available data indicating the role of diet in the intensity of cobalt entry into the human body
(Hokin B. et al., 2004; EFSA Panel on Additives, 2009; Tvermoes B.E. et al., 2015).  The results of the
kinetics research of the bivalent cobalt ions (Co2+) in the human body demonstrate that the maintenance of
stable systemic indicators of this ion can be enchanced by the binding of the cation to plasma polyanion
proteins (e.g. albumin);  accumulation of significant amounts of Co2+   inside erythrocytes;  its intense
reabsorption by tubular nephron epithelium (Tvermoes B.E. et al., 2015).  The predominant pathways for
cobalt excretion out the body of humans and other mammals are the kidneys and the gastrointestinal tract
(Gál J. et al., 2008; Tvermoes B.E. et al., 2015).  The intensity of renal clearance of Co2+ rather accurately
reflects the balance of the soluble ion fraction in the extracellular body fluid (EFSA Panel on Additives,
2009;  Tvermoes  B.E.  et  al.,  2015).   A  modern  methodology  for  estimating  the  level  of  cobalt
consumption in human populations can be based on an analysis of the Co2+   dynamics  in the blood and
urine (Tvermoes B.E. et al., 2014; 2015; Unice K.M.et al., 2012; Wei B. et al., 2018).  Along with this, in
population studies it is quite interesting to compare the dynamics of cobalt content in the various human
blood and hair samples (Wei B. et al., 2018).  The parallel between the metabolic pathways in the human
body of the Ca2+ and Co2+ cations is emphasized suggesting a preferential distribution of those cations in
the intravascular fluid, in erythrocytes and in specialized cellular organelles of certain tissues with high
rates  of  Ca2+ metabolism  (Simonsen  L.O.  et  al.,  2012).   In  particular,  in  the  rat  experiments  the
cardiotoxic effect of bivalent cobalt salts was demonstrated mainly due to the accumulation of the Co 2+
cation inside the cardiomyocytes (Gál J. et al., 2008).  On the other hand, experimental evidence is given
for the thesis stating that the intracellular metabolism of Co2+ may be closely linked with the metabolism
of  Zn2+  ions  and the  transport  system of  positively charged aminoacids  through cationic  amino acid
transporter - Cat1 (Ryuko S. et al., 2012).
 There are several reasons why the development of effective methods for assessing the levels of Co 2+
intake  and  the  study  of  its  kinetics  in  the  human  body  can  have  practical  importance.   Firstly,
physiologically  active  Co2+  -containing  complex  compounds  (cobalamins)  are  vital  for  the  normal
biochemistry of physiological processes.  Secondly, cobalt mineral salts (Co2+) are constantly present in
food products, mainly of animal origin (EFSA Panel on Additives, 2009).  The obtained data suggests
that the permissible rate of daily intake of Co2+ into the human body may be limited up to 1000 μg / day
(Unice K.M. et al., 2012).  According to other data, the permissible daily intake dose for Co 2+ is about
600 μg / day (EFSA Panel on Additives, 2009).  The existing sanitary norms of the Republic of France
stipulate the limiting values of the permissible daily consumption of Co2+ (depending on age), which are
1.6-8 µg / kg bw / day (Leyssens L. et al., 2017).  Given that normal food intake of cobalt ions is, on
average, 0.012 mg day−  1 per person, reaching higher values in some populations of India 0.23 mg day−1
and Japan 0.036 mg day−1 (Gál J. et al., 2008).  Excessive physiological norms of oral consumption of
Co2+ can cause toxic effects, activating the processes of mutagenesis, carcinogenesis and tissue necrosis
through the induction of reactive oxygen species formation and suppressing the work of DNA repair
systems (M. De Al., 2003; EFSA Panel on Additives, 2009; Simonsen  LO et al., 2012; Paustenbach DJ et
al.,  2013), activation of pro-inflammatory factor products (Liang Y. et al., 2017), thyroid dysfunction
(Yorita Christensen KL, 2013; Paustenbach DJet al., 2013;  Tvermoes BE et al., 2015), increased risk of
cardiomyopathy (Paustenbach DJ et al., 2013), encephalopathy  and congenital birth defects (EFSA Panel
on Additives, 2009; Catalani S. et al., 2012; Dai Y. et al., 2013).  The obtained data from population-
based studies confirms that higher levels of cobalt intake into the human body may lead to a decrease in
visual acuity (Mendy A. et al., 2012).
 In humans as well as in other mammals the mineral salts of Co 2+ do not participate in the processes of
biosynthesis of cobalamins by the intestinal microflora (Gál J. et al., 2008; EFSA Panel on Additives,
2009).  At the same time we have obtained some data reports indicating that Co2+ ions coming from food
(not included in cobalamins) can cause regulatory effects mediated by the production of physiologically
active  substances  that  act  as  a  kind  of  cation  mediators  in  relation  to  various  tissues  and  organs.
Primarily, these effects are related to hypoxia-inducible factor (HIF) (Salnikow K. et al., 2000; Yuan Y.et
al., 2003; Maxwell P., Salnikow K., 2004; Gál J. et al.,  2008; Jelkmann W., 2012; Muñoz-Sánchez J.,
Chánez-Cárdenas  ME,  2018).   Meanwhile,  that  particular  influence  of  cobalt  on  the  body which  is
mediated through the hypoxia-inducible factor does not  entirely correspond to the generally accepted
views on the toxic effects of cobalt substances.  Perhaps, therefore, over the past two decades, this unit of
research has quite clearly transformed into an independent research direction.  The presence of its own
specific approaches and research methods allows it to interfere productively a range of issues concerning
the pathophysiological and regulatory aspects of the Co2+ influence on the human body.  In our opinion,
this is the direction that is the most promising and relevant for both fundamental science and practical
medicine.
Consequently, the purpose of our data analysis is to provide the current information about the regulatory
and pathophysiological effects of Co2+ in the human body regarding the systemic, tissue and molecular
levels after toxic food intake or during accumulation of the cobalt cation in the extracellular body fluid.
2. TOXIC EFFECTS OF COBALT
 In the context of the facts under consideration, information on the pronounced direct toxic effects of
cobalt can appear to be rather interesting  because it allows to make a clearer distinction between the
mechanisms of the regulatory and toxic effects of Co2+.  It should be noted that the origin of the toxic
effects and the level of the toxic dose of cobalt cation largely depend on the way how it enters the body:
oral, inhalation or transcutaneous.  According to some authors, the threshold values of its oral intake were
identified, the excess of which causes a toxic effect.  In particular, for oral administration of Co 2+, the
minimum risk threshold is associated with daily ion intake of about 0.01 mg Co / kg body weight / day
(EFSA Panel on Additives, 2009).  The review shows that induced Co2+ cardiomyopathy can be caused by
food intake of an ion within 0.04 to 0.14 mg Co / kg / day.  There is an opinion on the relevance of
studies aimed at substantiating the threshold levels of Co2+ compounds in the human body (Leyssens L. et
al., 2017) since the proportion of anthropogenic factor in the bioavailability of this chemical element for
humans has significantly increased.  It has been suggested that the threshold values of the systemic toxic
effects of Co2+ may be due to the saturation of the intravascular deposition systems of the cation (plasma
proteins and erythrocytes) and an increase in the concentration of free (ionized) cobalt in  the extracellular
fluids (Tvermoes BE et al., 2015; Leyssens L.  et al., 2017).  
Hence, not only the levels of food intake of metal ions, but the state, for example, of protein metabolism,
can determine the degree of Co2+ toxicity.  Indeed, there are direct evidences that a low protein diet can be
considered as an additional risk factor for the development of the toxic effects of Co2 + (EFSA Panel on
Additives, 2009).  The results of clinical studies also confirmed the ability of plasma proteins to bind Co2+
ions, emphasizing the possible role of this mechanism in the neurotoxic effects of metal cations (Catalani
S. et al., 2011).
 The available data suggests that the direct toxic effects of Co2+ on humans and animals occur mainly due
to the elevation of reactive oxygen species resulting in the activation of lipid peroxidation and proteins,
followed by severe  destructions of nucleic acids and the suppression of DNA repair systems ( Jomova
K., Valko M., 2011; Leyssens L. et al., 2017).  It is indicated that the application of antioxidants reduces
the toxic effect of cobalt (Jomova K., Valko M., 2011, Zadnipryany I.V. et al., 2017).  The authors of the
cited review indicate that  not  only salts,  but  also metallic cobalt  possess genotoxic properties,  while
cobalt  compounds,  for  example,  with tungsten or  tungsten carbide,  can enhance their  genotoxic  and
carcinogenic properties.
 Meanwhile,  there  is  the  evidence that  direct  damage to mitochondria  can be considered as  another
pathogenetic  mechanism  of  polyorganic  disorders  induced  by  cobalt  salts  (Wang  G.  et  al.,  2000).
According to the authors of the cited publication, the toxic effect of Co2 + on mitochondria contributes to
the development of oxidative stress and damage to mitochondrial DNA regardless of the nuclear DNA
damage.  In vitro studies on murine embryonic stem cells revealed that cobalt dichloride CoCl2 enhances
the formation of reactive oxygen species, reduces the level of antioxidant defense, promotes the release of
cytochrome C from mitochondria into the cytoplasm and finally activates mitochondrial cell apoptosis
(Lee J.-H. et al., 2013).  The authors highlighted that toxic effects of cobalt dichloride depend on the dose
and time of exposure of the cells to their growth medium containing heavy metal ions.  It was reported
that cobalt  dichloride was able to induce the formation of a superoxide anion in the mitochondria of
various types of human cells (Chamaon K. et al., 2019).
 In our opinion, it should be taken into account that the toxic levels of Co2+ can have a specific effect on
the immune system.  In particular, studies on human monocytes and neutrophils in vitro have shown that
Co2+ cations activate the Toll-like receptor-4 (TLR4) of leukocytes, stimulating cell migration, resulting
in increased production of pro-inflammatory cytokines and the formation of foci of infiltrates (Lawrence
H. et al., 2016).  On the other hand, the induced by Co2+ Toll-like receptor-4 is expressed on the human
microvascular endothelial cells (Anjum S.A. et al., 2016).  So, the cited results go in a good agreement
with the previously obtained information about Co2+-dependent induction of TLR4 in murine peritoneal
macrophages is accompanied by the overproduction of pro-inflammatory cytokines and tissue hormones
(Shweta. Et al., 2015).
Nevertheless, the analysis of the toxic properties of a substance should be always based on the results of
the study of its kinetics in the human body.  On the one hand, a number of organs (myocardium, liver,
kidneys) with the ability to accumulate Co2+ ions (Simonsen L.O. et al., 2012; Tvermoes B.E. et al., 2014)
have been identified.  There is indication of a change in metabolic processes in the liver and kidneys of
rats exposed to prolonged exposure  to cobalt  dichoride at  a  dose of 12.5 mg cobalt  kg -1 for  7 days
(Shrivastava K. et al.,  2010).  Pathomorphological studies have shown that cobalt  dichloride leads to
dose-dependent structural disorders of the liver and myocardial tissue (Liu Y.et al., 2010).  In the context
of the previously discussed issues, it is important to emphasize that the tissues characterized by a high
intensity of Ca2+ metabolism can be considered as the target for the toxic effects of Co 2+ (Simonsen L.O.
et al., 2012).  Indeed, the results of experimental studies suggest that salts of Co2+ triggered the necrotic
changes in the heart and kidneys (Akinrinde A.S. et al., 2016; Oyagbemi A.A. et al., 2019).  Skeletal
musculature can be also considered as a Co2+ target organ.  It has been established that Bcl-2 adenovirus
E1B interacting  protein-3  (BNIP3)  is  an  important  component  in  muscle  tissue,  determining  Co2+ -
induced  autophagy  via  the  HIF  -  BNIP3  (Chen  R.  et  al.,  2017).   In  connection  with  these  facts,
information about the mechanisms of Co2+ ion entry into the cell and into the mitochondria can be quite
helpful.  Divalent metal ion transporter 1 (DMT1) (Muñoz-Sánchez J., Chánez-Cárdenas M.E., 2018) is
considered to be the main channel of Co2+ entry (as well as divalent ions of iron and nickel).  However, it
is reported that the transport of the histidine aminoacid through the cationic amino acid transporter - Cat1
can also be involved in the absorption of cobalt cations, whereas the Zhf1 transport protein, which is
responsible for the metabolism of zinc ions, can detoxify cells from cobalt cations (Ryuko  S. et al.,
2012).  According to the current references, the further entry of the Co2+  from the cytoplasm into the
mitochondrial matrix is  carried out according to the equivalent transport mechanism of Ca2+  and other
bivalent  metal  ions  -  the  mitochondrial  permeable  transitional  pore  mechanism  mediated  by  the
mitochondrial potential (Feng W. et al., 2016).  In addition, the authors draw attention to the fact that Co 2+
ions alike Ca2+ ions, can influence the system of mitochondrial translocations.
 On the other hand, the results of in vitro studies on the culture of cardiomyocytes made it possible to
establish that the toxic properties of cobalt dichloride occur due to a direct toxic effect on the state of
redox processes in mitochondria that triggers the cell apoptosis (Niu N. et al., 2019).  Perhaps a feature of
the cardiotoxic action of Co2+ is the disruption of the fundamental processes of energy metabolism in
mitochondria which are not capable to maintain the adequate contractile functions of cardiomyocytes
affecting both  systole and diastole  (Hantson P., 2019).  Arguments confirming damage to mitochondria
by cobalt (Co2+) ions of the tricarboxylic acid cycle (Kurhaluk N. et al., 2019; Hantson P., 2019) are also
being discussed.  In vitro studies there have been established that cobalt dichloride stimulates oxidative
stress and apoptosis in a dose-dependent manner (He Y. et al., 2018).  The authors showed that Co2+ ions
stimulate  the  expression  of  dynamin-related  protein  1  (Drp1),  which  determines  the  pathogenetic
mechanisms of cell death: a decrease in the mitochondrial membrane potential, a decrease in ATP level,
the stimulation of the formation of reactive oxygen forms.  The mechanisms of cell apoptosis caused by
mitochondrial damage and excessive stimulation of oxidative stress are considered to be the universal
pathogenetic mechanism of Co2+ induced damage to the central nervous system (Catalani S.et al., 2012).
It is also impossible to exclude the fact that a synergistic factor determining the nature of the influence of
cobalt dichloride on the fundamental metabolic processes (Krebs cycle activity, electron transport rate by
cytochromes and mitochondrial DNA transcription activity) in the mitochondria can be considered as the
hypoxia-inducible factor (Saxena S. et  al., 2012).
Nowadays  attention  is  drawn  to  the  fact  that  most  authors,  discussing  the  toxic  effect  of  Co2+ on
mitochondria, point to increased production of reactive oxygen species and the induction of apoptosis, as
two closely related effects.   Meanwhile, in the literature there are reports that such close relationship
between oxidative stress and apoptosis is more typical for the pure metallic cobalt (Liu Y. et al., 2017).
At the same time, the authors of the cited publication provide the data that the path of stimulation of
apoptotic signals  by Co2+ ions may not be directly related to the activation of oxidative stress.
3. PATHOPHYSIOLOGICAL EFFECTS OF Co2 +
 An important aspect of the problem under discussion is that cobalt mineral salts, those which are not part
of cobalamins, can have their own regulatory effect on the state of metabolic processes in the human
body.   Cobalt  salts  (Co2+)  have  been  used  for  a  long  time  as  a  pharmacological  stimulators  of
hematopoiesis in the treatment of anemias (Ebert B., Jelkmann W., 2014; Hoffmeister T. et al., 2019).
Further studies have shown that  hypoxia-inducible factor is  the leading mediator that  determines the
pathway and intensity of the effects of cobalt mineral salts on the human body (Salnikow K. et al., 2000;
Maxwell P., Salnikow K., 2004).  The question regarding the feasibility of pharmacological treatment of
anemia with cobalt hematopoietic salts was withdrawn from wide practical application in the 70s of the
20th century.  Meanwhile, the possible aspects of using cobalt mineral salts, mainly in the form of Co2+
still remain in the field of interests of modern practical medicine and is reflected in a number of modern
publications (Tanaka T. et al., 2005; Shrivastava K. et al., 2008; Chai YC et al., 2018 ).
 According  to  the  modern  references  the  hypoxia-inducible  factors  are  considered  to  be  the  main
mediators of the regulatory and pathophysiological effects of the Co2+ salts (Salnikow K. et al., 2000;
Maxwell P., Salnikow K., 2004; Muñoz-Sánchez J., Chánez-Cárdenas M.E., 2018).  An analysis of the
possible mechanisms of Co2+-dependent induction of hypoxia-inducible factors allowed to express the
opinion that the suppression of the metabolic clearance of HIF-1α as a result of Co2+-induced decrease in
the enzymatic activity of prolyl hydroxylases is not likely to be associated with the replacement of the
Fe2+ ion with Co2+ in the enzyme catalytic center  (Karaczyn A. et al., 2006; Kaczmarek M. et al., 2006;
Muñoz-Sánchez J., Chánez-Cárdenas ME, 2018).  According to the authors of the cited publications, the
more likely mechanism of Co2+-dependent stabilization of HIF-1α is depletion in the presence of Co2+ions
of intracellular reserves of ascorbic acid, which is crucial for the reduction of Fe 3+ to Fe2+ in the active
center of prolyl hydroxylases. Some  data represents the role of Co2+ in the metabolic clearance of HIF-1α
with the participation of von Hippel-Lindau protein (Yuan Y. et al., 2003), as well as in the stimulation of
HIF-1α translation (Muñoz-Sánchez J., Chánez-Cárdenas M.E., 2018).
 However, by analyzing the effects of the Co2+ salts bounded with the stabilization of HIF-1α, a unique
pattern can be revealed that is not observed during review the basic pathogenetic mechanisms of the toxic
effects of this metal.  Firstly, the direct toxic effects of Co2+ mineral salts are considered as a uniquely
negative factor.  At the same time, in the case of low levels of Co 2+ intake not over exceeding   the toxic
threshold values, in addition to negative body reactions, we can observe physiological effects which are
potentially applicable in practical medicine.  For example, in earlier studies it was suggested that cobalt
dichloride could serve as a promising adaptogen in the conditions of hypobaric hypoxia (Shrivastava K. et
al., 2008).  The results of later studies show the promising outcomes of cobalt in vitro application in
regenerative medicine in order to: form HIF-1α-dependent Co2+ induce stem cells of a certain phenotype
(Jeon ES et al., 2014), create conditions that are optimal for implant engraftment (Chai YC et al. , 2018)
and   to  control  osteogenic  differentiation  (Chen  Y.  et  al.,  2019).  Along  with  this,  the  results  of
nephroprotective properties of cobalt salts were obtained in in vivo studies (Matsumoto M. et al., 2003;
Tanaka  T.  et  al.,  2005).   Considering  the  previously  identified  HIF-1α-dependent  nephroprotective
properties of Co2+, the use of organometallic cobalt complexes have been proposed, which are able to
provide strictly supervised intrarenal level of Co2+ production in order to inhibit interstitial fibrosis (Tan
L. et al., 2019).
Secondly, the ability of Co2+ ions to stabilize HIF-1α is considered to be a pleiotropic pathophysiological
mechanism of cation influence associated with the production of various physiologically active molecules
and affecting the mitochondrial function (Stenger C. et al., 2011; Chimeh U. et al., 2018; Muñoz-Sánchez
J., Chánez-Cárdenas M.E., 2018).  In regard to this statement, the warnings that cobalt mineral salts are
not  the  mandatory  component  of  the  human  diet  and  their  food  consumption  should  be  strictly
standardized  are  absolutely  reasonable  (Jelkmann  W.,  2012;  Simonsen  L.O.  et  al.,  2012;  Ebert  B.,
Jelkmann W., 2014).  Indeed, research results show that even relatively low levels of cobalt dichloride
intake can cause vivid changes in metabolic processes in the myocardium and in the renal parenchyma
(Akinrinde A.S. et al., 2016; Oyagbemi A.A. et al., 2019).  It was also established that cobalt dichloride
even in the low doses not  exceeding the toxic threshold,  may trigger the tissue fibrosis and necrosis
(Kong D. et al., 2015).
In earlier publications, there is evidence of demand for biomonitoring of the presence of Co 2+ in human
food, emphasizing the versatility of such pathophysiological reactions, such as inflammation, in response
to the presence of a cation in the body (Simonsen L.O. et al., 2012; Czarnek K. al., 2015).  Also, it is
necessary to point out that the authors of the cited reviews emphasize the role of HIFs proteins in the
realization of the pathophysiological effects of cobalt.  It is possible that a more significant range of
pathophysiological reactions to the intake of Co2+ can be related with the number of HIF-1α-dependent
regulatory effects of Co2+ (Nagasawa H., 2011; Eskandani M. et al., 2017).  In particular, it is indicated
that  inflammation  can  be  considered  as  one  of  the  pathogenetic  HIF-1α-related  effects  of  hypoxia
(Eskandani M. et al., 2017).  There are also grounds to believe that Co2+ ions stimulate the expression of
the cyclooxygenase-2 protein gene, against the background of a decrease in the enzymatic activity of
endothelial NO-synthase complexes (Liang Y. et al., 2017).  In vitro studies have shown that Co2+ have
the ability to activate in macrophages the biosynthesis of inducible NO synthase and pro-inflammatory
interleukins (Kumanto M. et al., 2017).  A number of publications emphasize the universal pathogenetic
role of the Toll-like receptor-4 (TLR4) of leukocytes in the body’s immune responses to salts of heavy
metals such as cobalt and nickel (Schmidt M. et al., 2010; Samelko L. et al., 2016).  It is interesting that
nanoparticles of metallic cobalt can also stimulate the dose-dependent production of human monocytic
IL-1β and TNF-α (Samelko L. et al.,  2016).  The authors of the cited publications also provide facts
confirming the role of the pro-inflammatory effect of cobalt and its compounds in the pathogenesis of the
immunopathologies of muscular and bone tissues.  However, there is evidence in the literature that cobalt
dichloride can induce immunosuppression by suppressing the action of pro-inflammatory factors (Kwak
J. et al., 2018).  Although, as we have already observed, the regulatory effects of the metal may depend on
the dose of exposure and some other experimental conditions.
 At  the  same time,  it  has  been shown that  cobalt  salts  in  the  liver,  in  subtoxic  concentrations,  can
stimulate the production of a transforming factor beta-pleiotropic cytokine, which determines cell cycle
restriction, stimulation of extracellular matrix protein synthesis combined with immunosuppressor effects
(Kong D. et al., 2015).  The authors of the cited source believe that the dynamics of TGF-beta production
reflects the risk of organ fibrosis and can act as the cancerogenic factor.  Attention is drawn to the fact
that  Co2+  -induced fibrosis may be systemic  and get  triggered by the generation of reactive oxygen
species, while the another heavy metal chromium ions (Cr3+) do not act this way (Xu J. et al., 2018).
 Discussing HIF-1α-dependent regulatory effects of Co2+ in our considertion, it is necessary to point out
another important area of research due to the ability of the metal to participate in the regulation of gene
expression through such mechanisms as covalent chromatin modification and synthesis of small non-
coding RNA.  This line of research is developing dynamically in the field of testing of new diagnostic
methods, and is also valuable in the development of a fundamentally new way to treat the most lethal
cancer cases (Permenter M.G. et al., 2013; Ratha S. et al., 2017; Li C.-L. et al ., 2018).
4. EPIGENETIC EFFECTS OF Co2+
 The earliest publications on this topic contain information that Co2+  can stimulate the transcription of
certain  proteins  independently of  the  intracellular  endogenous  production  of  reactive  oxygen species
(Salnikow K. et al., 2000).  Further, directly induced by Co2+ HIF-1α-dependent epigenetic mechanisms
associated with enzyme DNA methylation and histone acetylation systems were evidenced (Maxwell P.,
Salnikow K., 2004).  In the modern reviews the role of epigenetic mechanisms in the implementation of
toxic and carcinogenic effects of heavy metals is widely emphasized (Salnikow K., Zhitkovich A., 2008;
Chervona Y, Costa M., 2012; Brocato J., Costa M., 2013).  The importance of the HIF-1α-dependent
epigenetic mechanisms induced by cobalt and other heavy metals is also recognized (Salnikow K. et al.,
2008; Nagasawa H., 2011; Brocato J., Costa M., 2013; Eskandani M. et al., 2017).  It was also shown that
stimulation  of  cobalt  dichloride  with  extracellular  matrix  deposits,  as  well  as  induction  of  vascular
endothelial growth factor and erythropoietin are associated with HIF-1α (Tanaka T. et al., 2005).  In our
opinion,  the  scientific  novelty of the proposed approach consists  in  the  fact  that  for  the first  time a
theoretical explanation of the pathogenesis of deadly oncological diseases induced by heavy metals was
explained and based on epigenetic mechanisms for controlling  of gene expression.  At the same time, the
pathogenesis of these diseases was not considered as a result of direct DNA damage.  The developed
approach  was  based  on  the  cancerogenic   effects  of  heavy  metals  caused  by  a  specific  covalent
modification of chromatin that alters gene expression (Salnikow K., Zhitkovich A., 2008; Salnikow K. et
al., 2008).  The sustainability of this approach was confirmed by subsequent research results (Chervona
Y, Costa M., 2012; Brocato J., Costa M., 2013).
 The  results  of  in  vitro  studies  on  cell  culture  of  multiple  myeloma  (B-cell  malignancy selectively
localized in the bone marrow) showed that the presence of cobalt chloride had a significant effect on the
levels of HIF-1α in cells, as well as on the state of expression of the genes identified as transcription
factors, cell differentiation markers, protein kinases, cytokines and growth factors, tumor suppressors, and
oncogenes (Bae S. et al., 2012).  According to the authors, they managed to isolate a group of genes
sensitive to Co2+ ions.  It was also established that cobalt dichloride, through the processes of acetylation
of  histone  proteins,  regulates  the  expression  of  extracellular-superoxide  dismutase  (Hattori  S.  et  al.,
2016).  On the other hand, valproic acid, and histone deacetylase inhibitors, has been shown to reduce the
pathophysiological effects of HIF-1α (Luo H.-M. et al., 2013; Kim Y.J. et al., 2017).
 Along with this, it was shown that HIF-1α can regulate not only the covalent modification of chromatin,
but also affect the biosynthesis of small non-coding RNAs capable of determining protein biosynthesis at
the level of transcription or translation (Kwak J. et al., 2018).  Indeed, there is evidence in the literature
that HIF may influence the metabolic systems of non-coding small RNAs (Ho J.J. et al., 2012; Ibrahim
A.A. et al., 2017).  At the same time, in vitro studies have established a link between the presence of
cobalt in the medium, HIFs with proteins, and the expression index of micro RNA cells (Silakit R. et al.,
2018).  There is evidence that HIF-dependent mechanisms, through the micro-RNA system, are involved
in  the  regulation  of  the  expression  of  pro-inflammatory  cytokines  (Kwak  J.  et  al.,  2018).   The
mechanisms of  Co2+ induction of  inflammation play an important  role  in  the  pathogenesis  of  cobalt
intoxication, however, the role of epigenetic mechanisms that determine the synthesis (including micro
RNA) of pro-inflammatory protein factors has not been studied deeply enough (Kumanto M. et al., 2017).
Conclusions
The relevance of studying the kinetics of heavy non-ferrous metals coming from the industrial objects is
determined by significant pollution of the modern ecosystems. Ecotoxicants affect all internal organs at
the molecular, cellular, tissue and systemic levels. The toxic effect of the damaging factor depends on its
concentration and exposure duration, its combination with the other damaging factors, chronic human
diseases and its immunological reactivity. 
One of the representatives of heavy non-ferrous metals is cobalt, which simultaneously belongs to the
group of microelements and therefore is vital for the functioning of living organisms, but at the same
time,  with  its  increased  intake,  it  is  toxic  to  the  body  and  even  destructive.  There  are  certain
concentrations in which cobalt is essential for living organisms. The main biological role of this element
is its presence in the molecule of water-soluble vitamin B12 (cyancobalamin), in which its mass fraction
is  4%.  However,  excessive intake of  cobalt  in  the  body is  geno-,  enzyme-and membrane-toxic.  The
toxicity of high concentrations of cobalt occur due to its hypoxic action, activation of lipid peroxidation
and depletion of antioxidant  systems.  Cobalt,  as an ion with variable valence,  severely induces lipid
peroxidation, promotes the formation of oxidative stress, which disrupts the function of the endothelium,
damages biological macromolecules of internal organs: organs of respiration, cardiovascular system, liver
and especially kidneys, where xenobiotics are neutralized. 
The  data  from  a  number  of  studies  indicate  a  toxic  effect  of  cobalt  chloride  on  the  kidneys  and
myocardium, characterized by the development of microangiopathy, fibrotic proliferation, stimulation  of
apoptosis and even necrosis. The basis of the toxic effect of heavy non-ferrous metal salts, including
cobalt, is the development of oxidative stress that can damage the cell and mitochondrial membranes and
cause  their  structural  and  functional  changes.  The  blocking  of  functionally  active  groups,  structural
proteins and functioning enzymes plays a significant role in the development of these disorders. Another
mechanism of the toxic effect of heavy metals on the body is their property to replace calcium ions in
specific processes.
The  toxic  effect  of  cobalt  has  been  studied  many times  and has  already been proven,  however  the
mechanisms of the damaging effect of cobalt at the molecular and DNA level have not yet been fully
studied.  Cobalt dichloride (CoCl2) has a similar effect to hypoxia due to expression of HIF-1α mRNA,
which indicates the dependence of the expression process of this mRNA not only according to oxygen
level, but also in the presence of iron ions. Cobalt is able for firmly binding with heme than iron. It was
also shown that cobalt activates HIF-1 due to depletion of the intracellular content of ascorbic acid, a co-
factor for HIF-hydroxylase, which destabilizes and inactivates HIF-1α. Hypoxia, as is known, is a typical
pathological process that accompanies and determines the development of many pathological conditions.
It leads to functional, and then structural changes in organs and tissues as a result of a decrease in the
intracellular concentration of oxygen. This also applies to hypoxia of tumor cells (intratumoral hypoxia).
Thus, many cancers include areas of hypoxia. Intratumoral hypoxia significantly worsens the prognosis of
the disease, since angiogenesis in the tumor tissues is very intense. This, apparently, is one of the reasons
for  the  rapid  growth  of  malignant  tumors  and  can  explain  cancerogenic  cobalt  effect.  In  addition,
enhanced angiogenesis in the tumor contributes to the metastasis of its cells, which ultimately increases
mortality  among such patients.  The principal  mechanism of  adaptation of  cancer  cells  to  hypoxia  is
activation of the HIF-1 factor. The elucidation of the pathogenetic role of the HIF-1α factor opens up new
possibilities not only in the correction of hypoxia, but also in the treatment of malignant tumors.
As  illustrated,  the  influence  of  cobalt  ions  on  the  body  should  be  researched  deeply,  as  well  as
interactions  between  cobalt  and  other  ions  and  aminoacids  occurring  in  body  fluid.  Perhaps  these
interactions can also have some specific and significant beneficial effects.
The authors declare no conflict of interest.
References
 Hokin B., Adams M., Ashton J., Louie H. Comparison of the dietary cobalt intake in three different 
Australian diets. Asia Pac J Clin Nutr, 2004;13(3):289-291
Gál J., Hursthouse A., Tatner P., Stewart F., Welton R. Cobalt and secondary poisoning in the terrestrial 
food chain: Data review and research gaps to support risk assessment. Environment International, 
2008,34:821–838 doi:10.1016/j.envint.2007.10.006 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP); Scientific 
Opinion on the use of cobalt compounds as additives in animal nutrition. EFSA Journal 2009;7(12):1383. 
[45 pp.].
doi:10.2903/j.efsa.2009.1383
Tvermoes B.E., Paustenbach D.J., Kerger B.D., Finley B.L., Unice K.M. Review of cobalt toxicokinetics 
following oral dosing: Implications for health risk assessments and metal-on-metal hip implant patients. 
Crit Rev Toxicol, 2015;45(5):367-387 doi: 10.3109/10408444.2014.985818 
Tvermoes B.E., Unice K.M., Paustenbach D.J., Finley B.L., Otani J.M.,  Galbraith D.A. Effects and blood
concentrations of cobalt after ingestion of 1 mg/d by human volunteers for 90 d.  Am J Clin Nutr 
2014;99:632–646 doi: 10.3945/ajcn.113.071449
Unice K.M., Monnot A.D., Gaffney S.H., Tvermoes B.E., Thuett K.A., Paustenbach D.J., Finley B.L. 
Inorganic cobalt supplementation: Prediction of cobalt levels in whole blood and urine using a biokinetic 
model. Food and Chemical Toxicology. 2012,50(7):2456-2461 https://doi.org/10.1016/j.fct.2012.04.009 
Leyssens L., Vinck B., Van Der Straeten C., Wuyts F., Maes L. Cobalt toxicity in humans.A review of 
the potential sources and systemic health effects.Toxicology http://dx.doi.org/10.1016/j.tox.2017.05.015 
Wei B., Yu J., Wang J., Li H., Yang L., Kong C.Trace Metals in the Urine and Hair of a Population in an 
Endemic Arsenism Area. Biol Trace Elem Res. 2018;182(2):209-216 doi: 10.1007/s12011-017-1108-x
Simonsen L.O., Harbak H., Bennekou P. Cobalt metabolism and toxicology--a brief update. Sci Total 
Environ. 2012;432:210-215  doi: 10.1016/j.scitotenv.2012.06.009
Ryuko S., Ma Y., Ma N., Sakaue M., Kuno T. Genome-wide screen reveals novel mechanisms for 
regulating cobalt uptake and detoxification in fission yeast. Mol Genet Genomics. 2012;287(8):651-662 
doi: 10.1007/s00438-012-0705-9
De Boeck M., Kirsch-Volders M., Lison D. Cobalt and antimony: genotoxicity and carcinogenicity. 
Mutat Res. 2003;533(1-2):135-152 PMID: 14643417
Simonsen L.O., Harbak H., Bennekou P. Cobalt metabolism and toxicology--a brief update. Sci Total 
Environ. 2012;432:210-215  doi: 10.1016/j.scitotenv.2012.06.009
Paustenbach D.J., Tvermoes B.E., Unice K.M., Finley B.L., Kerger B.D. A review of the health hazards 
posed by cobalt. Crit Rev Toxicol. 2013;43(4):316-362  doi: 10.3109/10408444.2013.779633 
Liang Y., Zhen X., Wang K., Ma J. Folic acid attenuates cobalt chloride-induced PGE2 production in 
HUVECs via the NO/HIF-1alpha/COX-2 pathway. Biochem Biophys Res Commun. 2017;490(2):567-
573 doi: 10.1016/j.bbrc.2017.06.079 
Yorita Christensen K.L. Metals in blood and urine, and thyroid function among adults in the United 
States 2007-2008. Int J Hyg Environ Health. 2013;216(6):624-32 doi: 10.1016/j.ijheh.2012.08.005
Wei B., Yu J., Wang J., Li H., Yang L., Kong C. Trace Metals in the Urine and Hair of a Population in an
Endemic Arsenism Area. Biol Trace Elem Res. 2018;182(2):209-216  doi: 10.1007/s12011-017-1108-x
Catalani S., Rizzetti M.C., Padovani A., Apostoli P. Neurotoxicity of cobalt. Hum Exp Toxicol. 
2012;31(5):421-437  doi:10.1177/0960327111414280
Dai Y.,  Li W., Zhong M., Chen J., Liu Y., Cheng Q., Li T. Preconditioning and post-treatment 
withcobalt chloride inrat model ofperinatal hypoxic–ischemic encephalopathy. Brain Dev. 2013 
http://dx.doi.org/10.1016/j.braindev.2013.04.007 
Mendy A., Gasana J., Vieira E.R. Urinary heavy metals and associated medical conditions in the US adult
population. Int J Environ Health Res. 2012;22(2):105-118  doi:10.1080/09603123.2011.605877
Yuan Y., Hilliard G., Ferguson T., Millhorn D.E. Cobalt inhibits the interaction between hypoxia-
inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha.
J Biol Chem. 2003;278(18):15911-15916 doi.1074/jbc.M300463200 
Maxwell P., Salnikow K. HIF-1: an oxygen and metal responsive transcription factor.Cancer Biol Ther. 
2004;3(1):29-35  PMID:14726713
Jelkmann W. The Disparate Roles of Cobalt in Erythropoiesis, and Doping Relevance.  Open Journal of 
Hematology, 2012, 3-6 doi: http://dx.doi.org/10.13055/ojhmt_3_1_6.121211  
Muñoz‐Sánchez J., Chánez‐Cárdenas M.E. The use of cobalt chloride as a chemical hypoxia model. J 
Appl Toxicol. 2018;39(4):1–15 doi: 10.1002/jat.3749
Catalani S., Leone R., Rizzetti M.C., Padovani A., Apostoli P. The Role of Albumin in Human 
Toxicology of Cobalt: Contribution from a Clinical Case.   ISRN Hematology. 2011; 2011, Article ID 
690620 doi:10.5402/2011/690620
Jomova K., Valko M.  Advances in metal-induced oxidative stress and human disease.  Toxicology. 2011;
283(2-3):65–87 doi:10.1016/j.tox.2011.03.001
Wang G.,Hazra T.K., Mitra S., Lee H.M., Englander E.W. Mitochondrial DNA damage and a hypoxic 
response are induced by CoCl(2) in rat neuronal PC12 cells. Nucleic Acids Res. 2000;28(10):2135-2140
Lee J.-H., Choi S.-H., Baek M.-W., Kim M.-H., Kim H.-J., Kim S.-H., Oh S.-J., Park H.-J.,  Kim W.-J., 
Jung J.-Y. CoCl2 induces apoptosis through the mitochondria- and death receptor-mediated pathway in 
the mouse embryonic stem cells.  Mol Cell Biochem. 2013;379:133–140 doi 10.1007/s11010-013-1635-5
Zadnipryany I.V., Tretiakova O.S., Sataieva T.P. & Zukow W., 2017, Experimental review of cobalt 
induced cardiomyopathy. Russian Open Medical Journal. 2017; 6(1): 1-4. 
doi: 10.15275/rusomj.2017.0103 
Chamaon K., Schönfeld P., Awiszus F., Bertrand J., Lohmann C.H. Ionic cobalt but not metal particles 
induces ROS generation in immune cells in vitro. J Biomed Mater Res B Appl Biomater. 
2019;107(4):1246-1253  doi: 10.1002/jbm.b.34217
Feng W., Zhang Y., Deng H., Li S.J. Interaction of divalent metal ions with human translocase of inner 
membrane of mitochondria Tim23. Biochem Biophys Res Commun. 2016;475(1):76-80 
doi:10.1016/j.bbrc.2016.05.039
Niu N.,  Li Z., Zhu M., Sun H., Yang J., Xu S., Zhao W., Song R. Effects of nuclear respiratory factor-1 
on apoptosis and mitochondrial dysfunction induced by cobalt chloride in H9C2 cells.  Molecular 
medicine reports. 2019;19(3):2153-2163  doi: 10.3892/mmr.2019.9839
Hantson P. Mechanisms of toxic cardiomyopathy. Clin Toxicol. 2019;57(1):1-9 
doi: 10.1080/15563650.2018.1497172
Kaczmarek M., Cachau R.E., Topol I.A., Kasprzak K.S., Ghio A., Salnikow K. Metal ions-stimulated 
iron oxidation in hydroxylases facilitates stabilization of HIF-1 alpha protein. Toxicol Sci. 
2009;107(2):394-403 
doi: 10.1093/toxsci/kfn251
Kurhaluk N., Lukash O., Nosar V., Portnychenko A.G., Portnychenko V., Wszedybyl-Winklewska M., 
Winklewski P.J. Liver mitochondrial respiratory рlasticity and oxygen uptake evoked by cobalt chloride lasticity and oxygen uptake evoked by cobalt chloride 
in rats with low and high resistance to extreme hypobaric hypoxia. Can J Physiol Pharmacol. 2019:1-8 
doi: 10.1139/cjpp-2018-0642
He Y., Gan X., Zhang L., Liu B., Zhu Z., Li T., Zhu J., Chen J., Yu H.. CoCl2 induces apoptosis via a 
ROS-dependent pathway and Drp1-mediated mitochondria fission in periodontal ligament stem cells. Am
J Physiol Cell Physiol. 2018;315(3):C389-C397 doi: 10.1152/ajpcell.00248.2017
Shrivastava K., Bansal A., Singh B., Sairam M., Ilavazhagan G. Sub-chronic oral toxicity study in 
Sprague-Dawley rats with hypoxia mimetic cobalt chloride towards the development of promising 
neutraceutical for oxygen deprivation. Experimental and Toxicologic. Pathology, Elsevier. 
2010;62(5):p.489
doi:10.1016/j.etp.2009.06.012
Liu Y., Xu H., Liu F., Tao R., Yin J.  Effects of serum cobalt ion concentration on the liver, kidney and 
heart in mice.  Orthopaedic Surgery. 2010;2(2):134–140 doi: 10.1111/j.1757-7861.2010.00076.x
Saxena S., Shukla D., Bansal A. Augmentation of aerobic respiration and mitochondrial biogenesis in 
skeletal muscle by hypoxia preconditioning with cobalt chloride. Toxicol Appl Pharmacol. 
2012;264(3):324-334  doi: 10.1016/j.taap.2012.08.033
Liu Y., Hong H., Lu X., Wang W., Liu F., Yang H. L-Ascorbic Acid Protected Against Extrinsic and 
Intrinsic Apoptosis Induced by Cobalt Nanoparticles Through ROS Attenuation. Biol Trace Elem Res. 
2017;175(2):428-439  doi: 10.1007/s12011-016-0789-x
Ebert B., Jelkmann W. Intolerability of cobalt salt as erythropoietic agent. Drug Test Anal. 
2014;6(3):185-189 doi: 10.1002/dta.1528
Akinrinde A.S., Oyagbemi A.A., Omobowale T.O., Asenuga E.R., Ajibade T.O. Alterations in blood 
pressure, antioxidant status and caspase 8 expression in cobalt chloride-induced cardio-renal dysfunction 
are reversed by Ocimum gratissimum and gallic acid in Wistar rats. J Trace Elem Med Biol. 2016;36:27-
37 doi: 10.1016/j.jtemb.2016.03.015
Oyagbemi A.A., Omobowale T.O., Awoyomi O.V., Ajibade T.O., Falayi O.O, Ogunpolu B.S., Okotie 
U.J., Asenuga E.R., Adejumobi O.A., Hassan F.O.., Ola-Davies O.E., Saba A.B., Adedapo A.A., Yakubu 
M.A. Cobalt chloride toxicity elicited hypertension and cardiac complication via induction of oxidative 
stress and upregulation of COX-2/Bax signaling pathway. Hum Exp Toxicol. 2019;38(5):519-532 
doi: 10.1177/0960327118812158
Kong D., Zhang F., Shao J., Wu L., Zhang X., Chen L., Lu Y., Zheng S. Curcumin inhibits cobalt 
chloride-induced epithelial-to-mesenchymal transition associated with interference with TGF-β/Smad 
signaling in hepatocytes. Lab Invest. 2015;95(11):1234-1245 doi: 10.1038/labinvest.2015.107
Hoffmeister T., Schwenke D., Wachsmuth N., Krug O., Thevis M., Byrnes W.C., Schmidt W.F.J. 
Erythropoietic effects of low-dose cobalt application. Drug Test Anal. 2019;11(2):200-207
doi: 10.1002/dta.2478
Salnikow K., Su W., Blagosklonny M.V., Costa M. Carcinogenic metals induce hypoxia-inducible factor-
stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res. 
2000;60(13):3375-3378 PMID: 10910041 
Tanaka T., Kojima I., Ohse T, Ingelfinger J.R., Adler S., Fujita T., Nangaku M.Cobalt promotes 
angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. 
Lab Invest. 2005;85(10):1292-1307 doi:10.1038/labinvest.3700328
Shrivastava K., Ram M.S., Bansal A., Singh S.S., Ilavazhagan G.Cobalt supplementation promotes 
hypoxic tolerance and facilitates acclimatization to hypobaric hypoxia in rat brain. High Alt Med Biol. 
2008;9(1):63-75  doi: 10.1089/ham.2008.1046
Chai Y.C., Mendes L.F., van Gastel N., Carmeliet G., Luyten F.P. Fine-tuning pro-angiogenic effects of 
cobalt for simultaneous enhancement of vascular endothelial growth factor secretion and implant 
neovascularization. Acta Biomater. 2018;72:447-460 doi: 10.1016/j.actbio.2018.03.048
Karaczyn A., Ivanov S., Reynolds M., Zhitkovich A., Kasprzak K.S., Salnikow K. Ascorbate depletion 
mediates up-regulation of hypoxia-associated proteins by cell density and nickel. J Cell Biochem. 
2006;97(5):1025-1035 doi:10.1002/jcb.20705
Yuan Y., Hilliard G., Ferguson T., Millhorn D.E. Cobalt inhibits the interaction between hypoxia-
inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha.
J Biol Chem. 2003;278(18):15911-15916 doi:10.1074/jbc.M300463200
Stenger C., Naves T., Verdier M., Ratinaud M.H.The cell death response to the ROS inducer, cobalt 
chloride, in neuroblastoma cell lines according to p53 status. Int J Oncol. 2011;39(3):601-609
doi:10.3892/ijo.2011.1083
Chimeh U., Zimmerman M.A., Gilyazova N., Li P.A. B355252, A Novel Small Molecule, Confers 
Neuroprotection Against Cobalt Chloride Toxicity In Mouse Hippocampal Cells Through Altering 
Mitochondrial Dynamics And Limiting Autophagy Induction. Int J Med Sci. 2018;15(12):1384-1396
doi:10.7150/ijms.24702
Shrivastava K., Ram M.S., Bansal A., Singh S.S., Ilavazhagan G.Cobalt supplementation promotes 
hypoxic tolerance and facilitates acclimatization to hypobaric hypoxia in rat brain. High Alt Med Biol. 
2008;9(1):63-75  doi: 10.1089/ham.2008.1046
Jeon E.S., Shin J.H., Hwang S.J., Moon G.J., Bang O.Y., Kim H.H.Cobalt chloride induces neuronal 
differentiation of human mesenchymal stem cells through upregulation of microRNA-124a. Biochem 
Biophys Res Commun. 2014;444(4):581-587  doi: 10.1016/j.bbrc.2014.01.114
Chen Y., Zhao Q., Yang X., Yu X., Yu D., Zhao W.. Effects of cobalt chloride on the stem cell marker 
expression and osteogenic differentiation of stem cells from human exfoliated deciduous teeth. Cell Stress
Chaperones. 2019 doi: 10.1007/s12192-019-00981-5
Matsumoto M., Makino Y., Tanaka T., Tanaka H., Ishizaka N., Noiri E., Fujita T., Nangaku M. Induction
of Renoprotective Gene Expression by Cobalt Ameliorates Ischemic Injury of the Kidney in Rats.  J Am 
Soc Nephrol 14: 1825–1832, 2003 PMID:12819242 
Tanaka T., Kojima I., Ohse T., Ingelfinger J.R., Adler S., Fujita T., Nangaku M. Cobalt promotes 
angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model.  
Laboratory Investigation. 2005;85: 1292–1307  doi:10.1038/labinvest.3700328
Tan L., Lai X., Zhang M., Zeng T., Liu Y., Deng X., Qiu M., Li J., Zhou G., Yu M., Geng X., Hu J., Li 
A. A stimuli-responsive drug release nanoplatform for kidney-specific anti-fibrosis treatment. Biomater 
Sci. 2019;7(4):1554-1564 doi: 10.1039/c8bm01297k
Nagasawa H. Pathophysiological response to hypoxia - from the molecular mechanisms of malady to 
drug discovery: drug discovery for targeting the tumor microenvironment. J Pharmacol Sci. 
2011;115(4):446-452 PMID: 21422725 
Eskandani M., Vandghanooni S., Barar J., Nazemiyeh H., Omidi Y. Cell physiology regulation by 
hypoxia inducible factor-1: Targeting oxygen-related nanomachineries of hypoxic cells. Int J Biol 
Macromol. 2017;99:46-62 doi: 10.1016/j.ijbiomac.2016.10.113
Czarnek K., Terpiłowska S., Siwicki A.K.Selected aspects of the action of cobalt ions in the human body.
Cent Eur J Immunol. 2015;40(2):236-242 doi:10.5114/ceji.2015.52837
Lawrence H., Deehan D.J., Holland J.P., Anjum S.A., Mawdesley A.E., Kirby J.A., Tyson-Capper A.J.. 
Cobalt ions recruit inflammatory cells in vitro through human Toll-like receptor 4. Biochem Biophys 
Rep. 2016;7:374-378  doi: 10.1016/j.bbrep.2016.07.003
Anjum S.A., Lawrence H., Holland J.P., Kirby J.A., Deehan D.J., Tyson-Capper A.J. Effect of cobalt-
mediated Toll-like receptor 4 activation on inflammatory responses in endothelial cells. Oncotarget. 
2016;7(47):76471-76478 doi: 10.18632/oncotarget.13260
Shweta., Mishra K.P., Chanda S., Singh S.B., Ganju L.A comparative immunological analysis of CoCl2 
treated cells with in vitro hypoxic exposure. Biometals. 2015;28(1):175-185 doi: 10.1007/s10534-014-
9813-9
Liang Y., Zhen X., Wang K., Ma J. Folic acid attenuates cobalt chloride-induced PGE2 production in 
HUVECs via the NO/HIF-1alpha/COX-2 pathway. Biochem Biophys Res Commun. 2017;490(2):567-
573
doi:10.1016/j.bbrc.2017.06.079
Kumanto M., Paukkeri E.-L., Nieminen R., Moilanen E. Cobalt(II) Chloride Modifies the Phenotype of 
Macrophage Activation.  Basic & Clinical Pharmacology & Toxicology, 2017;121:98–105
doi: 10.1111/bcpt.12773
Schmidt M., Raghavan B., Müller V., Vogl T., Fejer G., Tchaptchet S., Keck S., Kalis C., Nielsen P.J., 
Galanos C., Roth J., Skerra A., Martin S.F., Freudenberg M.A., Goebeler M. Crucial role for human Toll-
like receptor 4 in the development of contact allergy to nickel. Nat Immunol.2010;11(9):814-819 
doi: 10.1038/ni.1919
Samelko L., Landgraeber S., McAllister K., Jacobs J., Hallab N.J. Cobalt Alloy Implant Debris Induces 
Inflammation and Bone Loss Primarily through Danger Signaling, Not TLR4 Activation: Implications for
DAMP-ening Implant Related Inflammation. PLoS ONE.2016; 11(7): e0160141 
doi:10.1371/journal.pone.0160141
Kwak J., Choi S.J., Oh W., Yang Y.S., Jeon H.B., Jeon E.S. Cobalt Chloride Enhances the Anti-
Inflammatory Potency of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells through the 
ERK-HIF-1α-MicroRNA-146a-Mediated Signaling Pathway. Stem Cells International/ 2018; 2018: 
Article ID 4978763
https://doi.org/10.1155/2018/4978763
Xu J., Nyga A., Li W., Zhang X., Gavara N., Knight M.M. Shelton J.C. Cobalt ions stimulate a fibrotic 
response through matrix remodelling, fibroblast contraction and release of pro-fibrotic signals from 
macrophages.  European Cells and Materials. 2018;36:142-155 
doi: 10.22203/eCM.v036a11
Chen R., Jiang T., She Y., Xu J., Li C., Zhou S., Shen H., Shi H., Liu S.  Effects of Cobalt Chloride, a 
Hypoxia-Mimetic Agent, on Autophagy and Atrophy in Skeletal C2C12 Myotubes. Biomed Res Int. 
2017; 2017: 7097580  doi:10.1155/2017/7097580
Permenter M.G., Dennis W.E., Sutto T.E., Jackson D.A., Lewis J.A., et al. Exposure to Cobalt Causes 
Transcriptomic and Proteomic Changes in Two Rat Liver Derived Cell Lines. PLoS ONE. 2013;8(12): 
e83751 doi:10.1371/journal.pone.0083751
Ratha S., Dasa L., Kokatea S., Ghosha N., Dixita P., Routb N., Singhc S.P.,  Chattopadhyaya S., 
Ashktorabd H., Smoote D.T., Swamyf M.M., Kunduf T.K., Croweg S.E., Bhattacharyya A.  Inhibition of 
histone/lysine acetyltransferase activity kills CoCl2-treated and hypoxia-exposed gastric cancer cells and 
reduces their invasiveness  Int J Biochem Cell Biol. 2017; 82:28–40 doi:10.1016/j.biocel.2016.11.014
Li C.-L., Xu Z.-B., Fan X.-L., Chen H.-X., Yu Q.-N., Fang S.-B., Wang S.-Y., Lin Y.-D., Fu Q.-L. 
MicroRNA-21 Mediates the Protective Effects of Mesenchymal Stem Cells Derived from iPSCs to 
Human Bronchial Epithelial Cell Injury Under Hypoxia.  Cell Transplantation. 2018;  27(3):571–583
doi: 10.1177/0963689718767159
Salnikow K., Zhitkovich A. Genetic and Epigenetic Mechanisms in Metal Carcinogenesis and 
Cocarcinogenesis: Nickel, Arsenic and Chromium.  Chem Res Toxicol. 2008; 21(1):28–44 
doi:10.1021/tx700198a
Salnikow K. , Aprelikova O., Ivanov S., Tackett S., Kaczmarek M., Karaczyn A., Yee H., Kasprzak K.S., 
Niederhuber J. Regulation of hypoxia-inducible genes by ETS1 transcription factor.  Carcinogenesis. 
2008;29(8):1493–1499 doi:10.1093/carcin/bgn088
Chervona Y, Costa M. The control of histone methylation and gene expression by oxidative stress, 
hypoxia and metals. Free Radic Biol Med. 2012; 53(5):1041–1047 
doi:10.1016/j.freeradbiomed.2012.07.020
Brocato J., Costa M. Basic Mechanics of DNA Methylation and the Unique Landscape of the DNA 
Methylome in Metal-Induced Carcinogenesis.  Crit Rev Toxicol. 2013;43(6):493-514 
doi:10.3109/10408444.2013.794769
Bae S., Jeong H.-J., Cha H.J., Kim K., Choi Y.M., An I.-S., Koh H.J., Lim D.J., Lee S.-J., An S. The 
hypoxia-mimetic agent cobalt chloride induces cell cycle arrest and alters gene expression in U266 
multiple myeloma cells. International journal of molecular medicine. 2012;30:1180-1186
doi: 10.3892/ijmm.2012.1115
Hattori S., Kamiya T., Hara H., Ninomiya M., Koketsu M., Adach T. CoCl2 Decreases EC-SOD 
Expression through Histone Deacetylation in COS7 Cells.  Biol. Pharm. Bull. 2016;39(12): 2036–2041
doi:10.1248/bpb.b16-00551 
Luo H.-M., Du M.-H., Lin Z.-L., Zhang L., Ma L., et al. (2013) Valproic Acid Treatment Inhibits 
Hypoxia-Inducible Factor 1α Accumulation and Protects against Burn-Induced Gut Barrier Dysfunction 
in a Rodent Model. PLoS ONE. 2013; 8(10): e77523 
doi:10.1371/journal.pone.0077523
Kim Y.J., Park S.J., Kim N.R., Chin H.S. Effects of Histone Deacetylase Inhibitor (Valproic Acid) on the 
Expression of Hypoxia-inducibleFactor-1 Alpha in Human Retinal Müller Cells. Korean J Ophthalmol. 
2017;31(1):80-85 
doi: 10.3341/kjo.2017.31.1.80
Ho J.J., Metcalf J.L., Yan M.S., Turgeon P.J., Wang J.J., Chalsev M., Petruzziello-Pellegrini T.N., Tsui 
A.K., He J.Z., Dhamko H., Man H.S., Robb G.B., Teh B.T., Ohh M., Marsden P.A. Functional 
importance of Dicer protein in the adaptive cellular response to hypoxia. J Biol Chem. 
2012;287(34):29003-29020
doi:10.1074/jbc.M112.373365
Ibrahim A.A., Schmithals C., Kowarz E., Köberle V., Kakoschky B., Pleli T.,  Kollmar O., Nitsch S., 
Waidmann O., Finkelmeier F., Zeuzem S, Korf H.W., Schmid T., Weigert A., Kronenberger B., 
Marschalek R., Piiper A. Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which 
Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition. 
Clin Cancer Res. 2017;23(14):3896-3905  doi: 10.1158/1078-0432.CCR-16-1762
Silakit R., Kitirat Y., Thongchot S., Loilome W., Techasen A., Ungarreevittaya P., et al. Potential role of 
HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells. PLoS
ONE. 2018;13(6): e0199827  https://doi.org/10.1371/journal.pone.0199827
